Pathological response calculation assessment remains accurate with reduced tumor bed examination after neoadjuvant immunotherapy in clinically detectable stage III melanoma.
Saved in:
| Title: | Pathological response calculation assessment remains accurate with reduced tumor bed examination after neoadjuvant immunotherapy in clinically detectable stage III melanoma. |
|---|---|
| Authors: | Rawson, R.V.1,2,3,4 (AUTHOR), Maher, N.G.1,2 (AUTHOR), Menzies, A.M.1,2,5,6 (AUTHOR), Lo, S.N.1,2,7 (AUTHOR), Mesbah Ardakani, N.8 (AUTHOR), Jackett, L.A.9 (AUTHOR), Vergara, I.A.1,2,7 (AUTHOR), Pennington, T.E.1,2,3,6 (AUTHOR), Shannon, K.F.1,2,3,6 (AUTHOR), Ch'ng, S.1,2,3,6 (AUTHOR), Gonzalez, M.1 (AUTHOR), Burton, E.M.10 (AUTHOR), Lucas, M.W.11 (AUTHOR), Reijers, I.L.M.11 (AUTHOR), Rozeman, E.A.11 (AUTHOR), Gyorki, D.E.12 (AUTHOR), Sandhu, S.9 (AUTHOR), Carlino, M.S.1,2,13,14 (AUTHOR), Howle, J.13 (AUTHOR), Khattak, M.15 (AUTHOR) |
| Source: | Annals of Oncology. Feb2026, Vol. 37 Issue 2, p206-216. 11p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2025.10.1237 |
